Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M176,486Revenue $M48,851Net Margin (%)15.9Altman Z-Score2.2
Enterprise Value $M195,038EPS $1.2Operating Margin %25.1Piotroski F-Score6
P/E(ttm)21.5Beneish M-Score-2.7Pre-tax Margin (%)20.0Higher ROA y-yN
Price/Book2.610-y EBITDA Growth Rate %2.3Quick Ratio1.3Cash flow > EarningsY
Price/Sales3.85-y EBITDA Growth Rate %4.2Current Ratio1.6Lower Leverage y-yY
Price/Free Cash Flow12.9y-y EBITDA Growth Rate %-8.2ROA % (ttm)5.6Higher Current Ratio y-yN
Dividend Yield %4.0PEG5.2ROE % (ttm)13.3Less Shares Outstanding y-yY
Payout Ratio %83.0Shares Outstanding M6,173ROIC % (ttm)17.0Gross Margin Increase y-yY

Gurus Latest Trades with PFE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFEKahn Brothers 2015-12-31 Reduce-0.59%$31.33 - $35.45
($33.17)
$ 28.49-14%Reduce -6.05%1,569,873
PFET Rowe Price Equity Income Fund 2015-12-31 Add0.28%$31.33 - $35.45
($33.18)
$ 28.49-14%Add 15.28%14,525,000
PFEVanguard Health Care Fund 2015-12-31 Reduce-0.25%$31.33 - $35.45
($33.17)
$ 28.49-14%Reduce -29.31%8,872,226
PFEKen Fisher 2015-12-31 Add0.03%$31.33 - $35.45
($33.18)
$ 28.49-14%Add 1.28%32,334,417
PFEJames Barrow 2015-12-31 Reduce-0.02%$31.33 - $35.45
($33.17)
$ 28.49-14%Reduce -0.76%53,862,996
PFEMario Gabelli 2015-12-31 Reduce$31.33 - $35.45
($33.17)
$ 28.49-14%Reduce -3.16%706,956
PFERichard Pzena 2015-12-31 Add$31.33 - $35.45
($33.17)
$ 28.49-14%Add 0.08%2,161,593
PFELeon Cooperman 2015-09-30 Buy 3.06%$30.82 - $36.15
($33.8)
$ 28.49-16%New holding4,830,595
PFEKahn Brothers 2015-09-30 Reduce-0.59%$30.82 - $36.15
($33.8)
$ 28.49-16%Reduce -5.85%1,671,039
PFEVanguard Health Care Fund 2015-09-30 Reduce-0.46%$30.82 - $36.15
($33.8)
$ 28.49-16%Reduce -35.29%12,550,992
PFEFirst Eagle Investment 2015-09-30 Add0.14%$30.82 - $36.15
($33.8)
$ 28.49-16%Add 41.13%6,090,294
PFECharles Brandes 2015-09-30 Reduce-0.08%$30.82 - $36.15
($33.8)
$ 28.49-16%Reduce -3.16%5,863,701
PFEJames Barrow 2015-09-30 Reduce-0.05%$30.82 - $36.15
($33.8)
$ 28.49-16%Reduce -1.95%54,274,453
PFEDavid Dreman 2015-09-30 Reduce-0.05%$30.82 - $36.15
($33.8)
$ 28.49-16%Reduce -74.15%6,443
PFEMario Gabelli 2015-09-30 Reduce-0.02%$30.82 - $36.15
($33.8)
$ 28.49-16%Reduce -10.96%730,005
PFET Rowe Price Equity Income Fund 2015-09-30 Reduce-0.02%$30.82 - $36.15
($33.8)
$ 28.49-16%Reduce -1.08%12,599,315
PFENWQ Managers 2015-09-30 Reduce-0.01%$30.82 - $36.15
($33.8)
$ 28.49-16%Reduce -0.35%4,357,477
PFEJoel Greenblatt 2015-09-30 Add0.01%$30.82 - $36.15
($33.8)
$ 28.49-16%Add 2.27%1,047,861
PFEKen Fisher 2015-09-30 Add0.01%$30.82 - $36.15
($33.8)
$ 28.49-16%Add 0.35%31,926,879
PFEDodge & Cox 2015-09-30 Add$30.82 - $36.15
($33.8)
$ 28.49-16%Add 0.07%45,266,436
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CANGIALOSI LORETTA VSr. Vice President, Controller 2015-07-30Sell24,704$35.65-20.56view
OLSON LAURIE JExecutive Vice President 2015-06-11Sell26,000$34.39-17.65view
HILL CHARLES HExecutive Vice President 2015-05-29Sell42,870$34.92-18.9view
SUSMAN SALLYExecutive Vice President 2015-03-12Sell46,179$34-16.71view
READ IAN CChairman & CEO 2015-03-05Sell67,500$34.62-18.2view
Dolsten MikaelPresident R&D 2015-03-05Sell58,298$34.46-17.82view
CANGIALOSI LORETTA VSr. Vice President, Controller 2015-02-13Sell104,000$34.73-18.46view
MADDALUNA ANTHONY JExecutive Vice President 2015-02-12Sell9,000$34.85-18.74view
DAMELIO FRANK AExecutive Vice President 2015-02-11Sell80,200$34.23-17.27view
DAMELIO FRANK AExecutive Vice President 2015-02-11Sell14,800$34.3-17.43view

Quarterly/Annual Reports about PFE:

    News about PFE:

    Articles On GuruFocus.com
    Is Apple the Next Altria? Feb 02 2016 
    UnitedHealth Likely to Build on Growth in the Health Care Sector Jan 05 2016 
    Third Avenue Management's Annual Report Dec 29 2015 
    5 Guru Picks in Volatile Biotech Industry Dec 23 2015 
    Jim Simons' Top Holdings Include VeriSign, Chipotle Dec 15 2015 
    A Fed Rate Hike: What Investment Options Await You Dec 15 2015 
    Cooperman's Big Bets Include Alphabet, Pfizer Dec 06 2015 
    Leon Cooperman Adds Google Holdings and Buys Pfizer Nov 23 2015 
    What's Lee Ainslie's Angle to Buy Into a Pharmaceutical Stalwart Yielding 3%? Nov 19 2015 
    Leon Cooperman Buys Several Health Care Companies, Brief Position in Valeant Nov 17 2015 

    More From Other Websites
    Pfizer To Reorganize After Allergan Buyout, With Saunders President Feb 08 2016
    Senator scrutinizes pharma links on government pain panel Feb 08 2016
    Senator scrutinizes pharma links on government pain panel Feb 08 2016
    The market in a minute: 5 stocks I really like Feb 08 2016
    Pfizer unveils management line up for combined company Feb 08 2016
    Pfizer unveils management line up for combined company Feb 08 2016
    [$$] Pfizer Outlines Post-Merger Management Slate Feb 08 2016
    Pfizer Names New Executives to Run Units After Allergan Deal Feb 08 2016
    Pfizer to create operating unit after Allergan deal closes Feb 08 2016
    9:36 am Pfizer details planned changes upon completion of pending combination with Allergan (Feb 08 2016
    Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan... Feb 08 2016
    Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan... Feb 08 2016
    4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now Feb 08 2016
    Where is Ronald Reagan When You Need Him? Feb 08 2016
    How Analysts View Pfizer and Merck After Earnings Feb 07 2016
    Call Martin Shkreli Whatever You Want, But Not A Pharma CEO Feb 05 2016
    Op-ed: On IEX, let the market decide Feb 05 2016
    String of Q4 Earnings Beat Fails to Revive Pharma ETFs Feb 05 2016
    Pfizer's Pipeline Productivity Is Improving Feb 05 2016
    It’s Time to Buy This Biotech Gem Feb 04 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    Daniel Seens
    ReplyDaniel Seens - 1 year ago
    PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK